Skip to content
Search

Latest Stories

Submit Guest Post

Boris Johnson defends under-fire virus 'test and trace' scheme

British prime minister Boris Johnson on Wednesday (3) defended a new "test and trace" system designed to stop a second wave of coronavirus infection, amid criticism about a lack of transparency.

The scheme, launched in England last week to coincide with the easing of lockdown restrictions, uses an army of 25,000 tracers to contact people who may have been exposed to the virus.


Anybody thought to be at risk of infection will have to self-isolate for 14 days, even if they have no symptoms.

The government aims to be able to trace the contacts of 10,000 people a day.

"NHS (National Health Service) Test and Trace started operating a week ago," Johnson told a daily briefing on the government's response to the outbreak.

"And already thousands of people are isolating who wouldn't have been doing so before this service was introduced. They are thereby protecting others and reducing the spread of the virus."

Johnson gave no exact figure and critics claim the scheme's launch was rushed to divert attention from public outrage over his most senior aide's breach of lockdown restrictions.

Workers have also claimed they were not highly trained or were doing nothing.

The head of a cross-party parliamentary health committee piled fresh pressure on the government, criticising the system's head, Dido Harding, for failing to give appropriate data.

"I hope you understand that our frustration is that it is very hard to scrutinise what the government is doing if we're not given the data that allows us to do that," said Jeremy Hunt.

He said Harding had been given advance notice she would be asked to provide data, and was "disappointed" she could not give figures for how many people had been contacted so far.

Britain's government has come under sustained pressure for its response to the outbreak. The country has officially counted nearly 40,000 deaths -- the second-highest number in the world.

It has been criticised for failing to introduce tougher social distancing measures and lockdown earlier, and for a lack of widespread testing and provision of protective equipment.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Weight loss pill

Foundayo is the latest GLP-1 treatment to receive UK approval in tablet form

Representational image: iStock

UK becomes first European nation to approve new weight-loss pill, but NHS access is still pending

  • The UK is the first European country to approve Eli Lilly’s Foundayo pill.
  • The tablet is taken once a day without food or water restrictions.
  • NHS availability will depend on a separate NICE assessment.

The UK has become the first European nation to approve a new daily weight-loss pill, giving patients another option beyond the injectable treatments that have dominated the GLP-1 market.

The Medicines and Healthcare products Regulatory Agency (MHRA) approved Eli Lilly’s orforglipron, sold under the brand name Foundayo, on August 10 for weight management and to improve blood sugar control in adults with type 2 diabetes.

Keep ReadingShow less